Biogen Pharmachem Industries Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported revenue was INR 20.5 million compared to INR 10.58 million a year ago. Net income was INR 19.41 million compared to INR 0.107 million a year ago. Basic earnings per share from continuing operations was INR 0.03. Diluted earnings per share from continuing operations was INR 0.03.
For the six months, revenue was INR 5.13 million compared to INR 23.1 million a year ago. Net income was INR 3.51 million compared to INR 2.12 million a year ago. Basic earnings per share from continuing operations was INR 0.01. Diluted earnings per share from continuing operations was INR 0.01.